{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:49:53Z","timestamp":1783104593950,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jtocrr.2022.100285","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T02:15:51Z","timestamp":1643076951000},"page":"100285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States"],"prefix":"10.1016","volume":"3","author":[{"given":"Huamao M.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Crossland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Hong Ignatius","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2022.100285_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/1535-7163.MCT-12-0620","article-title":"EGFR Exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics","volume":"12","author":"Arcila","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtocrr.2022.100285_bib4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jtho.2018.06.019","article-title":"Diverse EGFR exon 20 insertions and co-occurring molecular alteration identified by comprehensive genomic profiling of NSCLC","volume":"13","author":"Riess","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100285_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247620","article-title":"Epidemiological and clinical burden of EGFR exon 20 insertion in advanced non-small cell lung cancer: a systematic literature review","volume":"16","author":"Burnett","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jtocrr.2022.100285_bib6","doi-asserted-by":"crossref","first-page":"102105","DOI":"10.1016\/j.ctrv.2020.102105","article-title":"EGFR exon 20 insertions in advanced non-small cell lung cancer: a new history begins","volume":"90","author":"Remon","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jtocrr.2022.100285_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-019-0038-9","article-title":"Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer","volume":"4","author":"Vyse","year":"2019","journal-title":"Signal Transduct Target Ther"},{"issue":"suppl 15","key":"10.1016\/j.jtocrr.2022.100285_bib8","article-title":"Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20 insertion (exon20ins)-mutated non-small cell lung cancer (NSCLC)","volume":"38","author":"Park","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100285_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.4761","article-title":"Treatment outcomes and safety of mobocertinib in platinum-pretreated patients with EGFR exon 20 insertion\u2013positive metastatic non-small cell lung cancer: a phase 1\/2 open-label nonrandomized clinical trial","volume":"7","author":"Zhou","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtocrr.2022.100285_bib12","author":"Ma"},{"key":"10.1016\/j.jtocrr.2022.100285_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jnci\/dji055","article-title":"Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers","volume":"97","author":"Shigematsu","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtocrr.2022.100285_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11523-020-00718-w","article-title":"Utilisation and determinants of epidermal growth factor receptor mutation testing in patients with non-small cell lung cancer in routine clinical practice: a global systematic review","volume":"15","author":"Thi","year":"2020","journal-title":"Target Oncol"},{"key":"10.1016\/j.jtocrr.2022.100285_bib15","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for non-small cell lung cancer, version 1.2022. NCCN.org. Accessed December 16, 2021."},{"key":"10.1016\/j.jtocrr.2022.100285_bib16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3390\/ijms20061431","article-title":"Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: new insights and future perspectives in this complex clinical scenario","volume":"20","author":"Russo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtocrr.2022.100285_bib17","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.jtho.2021.01.112","article-title":"FP07. 12 Underdiagnosis of EGFR exon 20 insertion mutation variants: estimates from NGS-based real-world datasets","volume":"16","author":"Bauml","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100285_bib18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1634\/theoncologist.2017-0493","article-title":"Hybrid capture-based comprehensive genomic profiling identifies lung cancer patients with well-characterized sensitizing epidermal growth factor receptor point mutations that were not detected by standard of care testing","volume":"23","author":"Suh","year":"2018","journal-title":"Oncologist"},{"issue":"suppl","key":"10.1016\/j.jtocrr.2022.100285_bib19","doi-asserted-by":"crossref","first-page":"S928","DOI":"10.1016\/j.jtho.2021.08.182","article-title":"MA14.01 distribution and detectability of EGFR exon 20 insertion variants in non-small cell lung cancer","volume":"16","author":"Ou","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100285_bib20","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.21037\/jtd.2018.09.108","article-title":"Exploratory analysis of introducing next-generation sequencing-based method to treatment- naive lung cancer patients","volume":"10","author":"Feng","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtocrr.2022.100285_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cllc.2017.04.004","article-title":"Genomic profiling of advanced non-small cell lung cancer in community settings: gaps and opportunities","volume":"18","author":"Gutierrez","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtocrr.2022.100285_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/genes12050679","article-title":"Sensitivity to immune checkpoint blockade in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutations","volume":"12","author":"Metro","year":"2021","journal-title":"Genes (Basel)"},{"issue":"suppl 15","key":"10.1016\/j.jtocrr.2022.100285_bib25","article-title":"Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations","volume":"39","author":"Ou","year":"2021","journal-title":"J\u00a0Clin Oncol"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:37:16Z","timestamp":1762987036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364322000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2666364322000108"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100285","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100285"}}